EFFECTS OF CHRONIC TREATMENT WITH DEXFENFLURAMINE ON SEROTONIN IN RAT-BLOOD, BRAIN AND LUNG-TISSUE

被引:41
作者
CELADA, P [1 ]
MARTIN, F [1 ]
ARTIGAS, F [1 ]
机构
[1] CSIC,CID,DEPT NEUROCHEM,E-08034 BARCELONA,SPAIN
关键词
DEXFENFLURAMINE; SEROTONIN; BLOOD; LUNGS; BRAIN;
D O I
10.1016/0024-3205(94)00663-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have examined the effects of continuous treatment (0.5, 1, 2.5 and 5 mg.kg(-) (1).day(-1) for 14 days, using minipumps) with dexfenfluramine (dF) on the concentration of serotonin (5-hydroxytryptamine, 5-HT) in blood, lungs and brain frontal cortex. 5-HT concentration was decreased in whole blood and tissues by the two higher doses (2.5 and 5 mg.kg(-1) day(-1)). The concentration of dF in plasma was above detection limit only in these two treatment groups. The concentration of 5-HT in plasma (extracellular) was not modified dose-dependently, although values higher than controls were noted in the 2.5 mg.kg(-1) group. Significant correlations were observed between the concentration of 5-HT in whole blood and that of 5-HT (and 5-HT + 5-HIAA) in frontal cortex. Both correlated inversely with the plasma concentration of dF. These results show that treatment with dF for two weeks reduces the concentration of intracellular 5-HT in peripheral stores (platelets, lung endothelial cells) without a concurrent increase of the extracellular 5-HT pool in blood. Correlation data suggest that whole blood 5-HT content may have a predictive value of dF-induced reductions of 5-HT in brain tissue after long-term treatment.
引用
收藏
页码:1237 / 1243
页数:7
相关论文
共 26 条
  • [1] DETERMINATION OF SEROTONIN IN WHOLE-BLOOD, PLATELET-RICH PLASMA, PLATELET-POOR PLASMA AND PLASMA ULTRAFILTRATE
    ANDERSON, GM
    FEIBEL, FC
    COHEN, DJ
    [J]. LIFE SCIENCES, 1987, 40 (11) : 1063 - 1070
  • [2] SEROTONIN IN BODY-FLUIDS - CHARACTERIZATION OF HUMAN PLASMATIC AND CEREBROSPINAL-FLUID POOLS BY MEANS OF A NEW HPLC METHOD
    ARTIGAS, F
    SARRIAS, MJ
    MARTINEZ, E
    GELPI, E
    [J]. LIFE SCIENCES, 1985, 37 (05) : 441 - 447
  • [3] INCREASED PLASMA-FREE SEROTONIN BUT UNCHANGED PLATELET SEROTONIN IN BIPOLAR PATIENTS TREATED CHRONICALLY WITH LITHIUM
    ARTIGAS, F
    SARRIAS, MJ
    MARTINEZ, E
    GELPI, E
    ALVAREZ, E
    UDINA, C
    [J]. PSYCHOPHARMACOLOGY, 1989, 99 (03) : 328 - 332
  • [4] PULMONARY-HYPERTENSION AND DEXFENFLURAMINE
    ATANASSOFF, PG
    WEISS, BM
    SCHMID, ER
    TORNIC, M
    [J]. LANCET, 1992, 339 (8790) : 436 - 436
  • [5] THE ROLE OF D-NORFENFLURAMINE IN THE INDOLE-DEPLETING EFFECT OF D-FENFLURAMINE IN THE RAT
    CACCIA, S
    ANELLI, M
    FERRARESE, A
    FRACASSO, C
    GARATTINI, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 233 (01) : 71 - 77
  • [6] GAS-LIQUID-CHROMATOGRAPHIC DETERMINATION OF OPTICAL ISOMERS OF FENFLURAMINE AND NORFENFLURAMINE IN BIOLOGICAL SAMPLES
    CACCIA, S
    JORI, A
    [J]. JOURNAL OF CHROMATOGRAPHY, 1977, 144 (01): : 127 - 131
  • [7] CAMPBELL DB, 1991, REV CONTEMP PHARMACO, V2, P93
  • [8] PLASMA 5-HYDROXYINDOLEACETIC ACID AS AN INDICATOR OF MONOAMINE OXIDASE-A INHIBITION IN RAT-BRAIN AND PERIPHERAL-TISSUES
    CELADA, P
    ARTIGAS, F
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) : 2191 - 2198
  • [9] CELADA P, 1992, J CLIN PSYCHOPHARM, V12, P309
  • [10] COHEN RA, 1985, SEROTONIN CARDIOVASC, P105